7 Biotechs Fighting Rare Diseases With Gene-Editing Tech
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases … Read More
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases … Read More
An exploration of the future of clinical hematology and oncology through precision medicine, drug development, and artificial intelligence.
Editorial column by Dr. Basem Goueli